NCT07326618Completed
Cinematic Virtual Reality Intervention for Improving Psychosocial Functioning in Individuals With Schizophrenia
The Use of Virtual Reality Application in Improving Psychosocial Dysfunction in Schizophrenia
Source: ClinicalTrials.gov · Last updated 12 Jan 2026
Brief summary (registry, in English)
Virtual reality (VR) is a novel and innovative intervention method increasingly used in psychiatric research and treatment. VR allows individuals to experience realistic, everyday social situations in a safe and controlled environment. This study aims to examine the effects of a cinematic VR-based psychosocial intervention on individuals with schizophrenia who experience reduced psychosocial functioning and social isolation. In this study, a Cinematic Virtual Reality Treatment Program (cVR-PTP) consisting of 12 weekly sessions was developed. Each session focuses on real-life social situations designed to support social interaction and daily functioning. The intervention aims to contribute to improvements in psychosocial functioning, social engagement, and overall functioning in individuals with schizophrenia.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 37 (actual)
- First submitted
- 24 Dec 2025
- Start date
- 12 Apr 2023
- Primary completion date
- 15 Mar 2024
- Lead sponsor
- Dokuz Eylul University
- Diseases
- Schizophrenia
- NCT number
- NCT07326618
What you commit to
- Study type: Interventional
- Participants enrolled: 37
- From 12 Apr 2023 to the primary completion date, 15 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received electroconvulsive therapy in the past 6 months
Other illness
- Having a diagnosis of a serious physical or neurological disorder that could impact clinical functioning or sensory systems (visual or auditory), alcohol or substance use disorder, intellectual disability, or a history of epilepsy
Other
- Experienced a psychotic episode or suicide attempt in the past 12 weeks
- Participants with an identified suicide risk, self-harm tendencies, or violent behavior
Who the study is looking for
- Clinical stability over the past 12 weeks
- No changes in antipsychotic medication during last 6 monhts
- Having a score ≤70 on the PSP and and ≤61 on the Social and Occupational Functioning Assessment Scale (SOFAS)
Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Psychiatry Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.